To determine whether the activation of JNK/p38 MAPK signaling by TFAM knockdown in NSCLC cells was due to ROS, TFAM-knockdown NSCLC and control cells were treated with the ROS scavenger NAC to measure both cellular and mitochondrial ROS levels. The gene discussed is TFAM; the disease is non-small cell lung carcinoma.